International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 40, 155–157 (2017).
Agiostratidou, G. et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 40, 1622–1630 (2017).
Article PubMed PubMed Central Google Scholar
Pedersen-Bjergaard, U., Faerch, L., Allingbjerg, M. L., Agesen, R. & Thorsteinsson, B. The influence of new European Union Driver’s License Legislation on reporting of severe hypoglycemia by patients with type 1 diabetes. Diabetes Care 38, 29–33 (2015).
Weinstock, R. S. et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry. J. Clin. Endocrinol. Metab. 98, 3411–3419 (2013).
Article CAS PubMed Google Scholar
Shamoon, H. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N. Engl. J. Med. 329, 977–986 (1993).
Henriksen, M. M., Andersen, H. U., Thorsteinsson, B. & Pedersen-Bjergaard, U. Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring. J. Clin. Endocrinol. Metab. 103, 2329–2335 (2018).
Pettus, J. H. et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study. Diabetes Care 42, 2220–2227 (2019).
Frier, B. M. Hypoglycemia in the diabetic adult. Baillieres Clin. Endocrinol. Metab. 7, 757–777 (1993).
Article CAS PubMed Google Scholar
Khunti, K. et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes. Metab. 18, 907–915 (2016).
Article CAS PubMed PubMed Central Google Scholar
Geddes, J., Schopman, J. E., Zammitt, N. N. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501–504 (2008).
Article CAS PubMed Google Scholar
Pedersen-Bjergaard, U. et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 20, 479–486 (2004).
Gonder-Frederick, L. A. et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care 32, 1001–1006 (2009).
Article PubMed PubMed Central Google Scholar
Jauch-Chara, K. et al. Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care 30, 2040–2045 (2007).
Article CAS PubMed Google Scholar
Lacy, M. E. et al. Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID). Diabetes Care 43, 541–548 (2020).
Article PubMed PubMed Central Google Scholar
Jacobson, A. M. et al. Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC study. Lancet Diabetes Endocrinol. 9, 436–445 (2021).
Article PubMed PubMed Central Google Scholar
Jacobson, A. M. et al. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842–1852 (2007).
George, E. et al. Preservation of physiological cell responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 20, 1293–1298 (1997).
Article CAS PubMed Google Scholar
Cryer, P. E. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54, 3592–3601 (2005).
Article CAS PubMed Google Scholar
Gerich, J. E., Mokan, M., Veneman, T., Korytkowski, M. & Mitrakou, A. Hypoglycemia unawareness. Endocr. Rev. 12, 356–371 (1991).
Article CAS PubMed Google Scholar
Hendrieckx, C. et al. Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Res. Clin. Pract. 103, 430–436 (2014).
Article CAS PubMed Google Scholar
Lawton, J. et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 37, 109–115 (2014).
Rubin, N. T. et al. Relationship between hypoglycemia awareness status on Clarke/Gold methods and counterregulatory response to hypoglycemia. J. Endocr. Soc. 6, bvac107 (2022).
Article PubMed PubMed Central Google Scholar
Lu, C. L., Shen, H. N., Hu, S. C., Wang, J. D. & Li, C. Y. A population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes. Diabetes Care 39, 1571–1578 (2016).
Khunti, K. et al. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38, 316–322 (2015).
Fahrmann, E. R., Adkins, L. & Driscoll, H. K. Modification of the association between severe hypoglycemia and ischemic heart disease by surrogates of vascular damage severity in type 1 diabetes during approximately 30 years of follow-up in the DCCT/EDIC study. Diabetes Care 44, 2132–2139 (2021).
Article CAS PubMed PubMed Central Google Scholar
Joy, N. G. et al. Acute and chronic effects of atomoxetine on symptom awareness and cognitive function during repeated hypoglycemia in healthy individuals [abstract 396-P]. Diabetes 64, A103 (2015).
Wright, R. J. et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33, 1591–1597 (2010).
Article CAS PubMed PubMed Central Google Scholar
Frier, B. M., Schernthaner, G. & Heller, S. R. Hypoglycemia and cardiovascular risks. Diabetes Care 34, S132–S137 (2011).
Article PubMed PubMed Central Google Scholar
Snell-Bergeon, J. K. & Wadwa, R. P. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol. Ther. 14, S51–S58 (2012).
Article CAS PubMed Google Scholar
Robinson, R. T., Harris, N. D., Ireland, R. H., Macdonald, I. A. & Heller, S. R. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes. Diabetologia 47, 312–315 (2004).
Article CAS PubMed Google Scholar
Murphy, N. P. et al. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia 47, 1940–1947 (2004).
Article CAS PubMed Google Scholar
Gruden, G. et al. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care 35, 125–127 (2012).
Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr. Pract. 16, 244–248 (2010).
Tattersall, R. B. & Gill, G. V. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 8, 49–58 (1991).
Article CAS PubMed Google Scholar
Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the ‘dead in bed’ syndrome revisited. Diabetologia 52, 42–45 (2009).
Article CAS PubMed Google Scholar
Novodvorsky, P. et al. Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care 40, 655–662 (2017).
Laing, S. P. et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet. Med. 16, 466–471 (1999).
Article CAS PubMed Google Scholar
American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes–2022. Diabetes Care 45, S83–S96 (2022).
Bailey, T. S. et al. Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an
留言 (0)